Molecular Diagnostics
Liquid Biopsy of Cerebrospinal Fluid for Diagnosis of Medulloblastoma
A recent study found that young patients with the aggressive brain cancer medulloblastoma have a unique molecular makeup in their cerebrospinal fluid, which might be useful for diagnosis and monitoring the presence of a tumor in the central nervous system. More...08 Mar 2022
Single-Antigen Assays Increase Clinical Laboratory's Ability to Identify Acceptable Donors for Transplants
A portfolio of newly-launched single antigen assays increases the ability of clinical laboratories to find acceptable donors in order to provide new beginnings for more transplant patients. More...08 Mar 2022
Biomérieux Launches Free Mobile App to Aid Clinicians in Emergency and Critical Care Diagnostics
A free mobile application aims to support clinicians in decision-making and monitoring of patients using emergency and critical care diagnostics. In hospitals, particularly for emergency cases, diagnostic options can be limited for patients with acute and complex pathologies. More...04 Mar 2022
Mitochondrial Damage May Explain the Increased Incidence of Hypertension in Black Adults
Increased plasma concentration of the enzyme xanthine oxidase (XO) and the resulting mitochondrial DNA damage that it can cause may explain why Blacks have a significantly higher incidence of hypertension than their White counterparts. More...03 Mar 2022
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
In Other News
TTMV-HPV DNA Biomarker Predicts Recurrence of Oropharynx Cancer
Two Important Cardiovascular Disease Risk Factors Operate Independently
Sensitive Diagnostic Test for Alzheimer’s Disease Demonstrates Accuracy Over Multiple Laboratories and Protocols
Novel Biomarkers Predict Response of Melanoma Patients to Immunotherapy
Whole-Genome Sequencing Diagnoses Neurological Repeat Expansion Disorders
High-Risk Subtype of Relapsed Pediatric Acute Myeloid Leukemia Revealed
C-reactive Protein Level Can Replace Erythrocyte Sedimentation Rate for Defining the Severity of Ulcerative Colitis
Genome Sequencing Investigated for Prenatal Diagnosis of Fetal Structural Anomalies
Genetic Signature Predicts Patients’ Response to Gastric Cancer Therapy
LumiraDx C-Reactive Protein (CRP) Test Achieves CE Marking
New Method for Three-Dimensional Analysis of Cancer Cells Shows Diagnostic Potential
Titin-Truncating Variant Associated With Late-Onset Dilated Cardiomyopathy
New Pathogen Detection Assay Pairs Molecular Inversion Probes, Next-Generation Sequencing
Metabolomics-Based Test Detects Early-Stage Lung Cancer and Predicts Patient Survival Time
Sensitive Protein Assay Differentiates Parkinson’s Disease from Other Synucleinopathies
World's First Genomic Test for Personalized HER2+ Breast Cancer Treatment Could Revolutionize Precision Oncology
dd-cfDNA Test for Assessing Kidney Transplant Rejection Performs Strongly in Real-World Study
CRISPR-based Assay Platform Detects Multiple Viruses and COVID-19 Variants
New In-Vitro Diagnostic Kits Help Patients Fight Cancer in Europe
Personalized Molecular Monitoring Assay Uses Algorithms for Early Detection of ctDNA
Molecular Profiling of Meningioma Leads to Improved Prognosis and Therapy
Aptamer-Based Test Identifies Biomarkers Linked to Neuropsychiatric Symptoms of Systemic Lupus Erythematosus
Rapid, Cheaper Test Identifies Specific Genetic Mutations in Patient’s Cancer Cells for Personalized Therapy
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.